SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001854270-22-000007
Filing Date
2022-07-19
Accepted
2022-07-19 16:21:49
Documents
12
Period of Report
2022-07-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K snti-20220713.htm   iXBRL 8-K 40576
  Complete submission text file 0001854270-22-000007.txt   181493

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20220713.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20220713_lab.xml EX-101.LAB 24831
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20220713_pre.xml EX-101.PRE 13043
6 EXTRACTED XBRL INSTANCE DOCUMENT snti-20220713_htm.xml XML 11271
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 221091808
SIC: 2836 Biological Products, (No Diagnostic Substances)